McKinsey Quantum Technology Monitor: Tracking Industry Quantum Advantage

McKinsey’s Quantum Technology practice, part of its Technology, Media, and Telecom group, publishes an annual Quantum Technology Monitor tracking commercial quantum progress across hardware, software, and applications. The 2024 edition of the report is the most quantitatively detailed yet, modeling the expected economic value of quantum computing across industries by constructing a bottom-up catalog of high-value use cases, mapping each to a quantum algorithmic family, estimating the size of the classical compute problem being addressed, and applying a time-discounted value-at-risk model that accounts for the probability and timeline of achieving fault-tolerant advantage in each domain. The headline figure is $1.3 trillion in potential annual economic value by 2035, concentrated in finance ($622B), pharmaceuticals ($327B), chemicals ($279B), and automotive ($82B). These four sectors lead because their highest-value problems, portfolio optimization, molecular simulation, reaction pathway prediction, and battery material design respectively, map directly to quantum algorithmic strengths in optimization and quantum chemistry simulation.

The report introduces a use case taxonomy across three algorithmic families. Optimization problems, including combinatorial logistics, portfolio construction, scheduling, and network routing, are addressed by quantum annealing and QAOA. These have the nearest-term advantage potential because small problem instances already show competitive performance on NISQ hardware without requiring full fault tolerance, and classical heuristics have known gaps that quantum can exploit. Simulation problems, including molecular energy calculations for drug discovery and materials science, require deeper circuits and more qubits and are therefore fault-tolerant-first, with McKinsey placing broad advantage here at 2030 and beyond. Machine learning problems, including quantum kernel methods and quantum neural networks, occupy an uncertain middle ground: theoretical advantage exists on certain structured datasets but has not been demonstrated convincingly on industry-scale data, and McKinsey assigns this category the widest uncertainty bounds. The time-to-advantage framework maps each use case to one of three windows: NISQ-era advantage (2025-2027) for select optimization problems where classical gaps are established, early fault-tolerant advantage (2027-2030) for hybrid simulation and large-scale optimization, and broad fault-tolerant advantage (2030+) for molecular simulation and large-scale ML.

McKinsey’s Quantum Advantage Tracker monitors 30+ active industry quantum projects across the leading sectors, scoring each on a five-point scale from proof-of-concept (score 1) to production deployment with validated advantage (score 5). As of the 2024 report, the portfolio distribution is heavily weighted toward scores 1 and 2, with finance leading at score 3 for quantum Monte Carlo on NISQ simulators and logistics at score 3 for D-Wave hybrid annealing in route and scheduling optimization. No project has yet reached score 5. The tracker serves as a benchmarking tool for enterprise chief technology officers and chief strategy officers evaluating their own quantum readiness relative to industry peers. McKinsey supplements the tracker with an investment prioritization methodology that combines quantum value potential (from the use case model), technology readiness (hardware and software maturity for the specific use case), and organizational readiness (internal quantum talent, data infrastructure, partnership access), producing a three-by-three prioritization matrix that firms use to sequence their quantum investments.

The report’s influence on corporate quantum strategy has been substantial. McKinsey tracks post-publication investment decisions among the 150+ enterprise clients briefed on the findings, and attributes accelerated quantum program funding at financial services firms in particular to the $622B finance valuation, which provides board-level justification for multi-year quantum research budgets. The macroeconomic context reinforces urgency:$35B in public and private quantum investment flowed in 2023, with national quantum programs in the United States (National Quantum Initiative), European Union (Quantum Flagship), China, Japan, and South Korea all scaling. The 32% CAGR for the quantum technology market, measured from hardware and software vendor revenues, suggests that the competitive landscape for both technology providers and enterprise adopters is changing faster than most strategic planning cycles. McKinsey’s Quantum Technology practice recommends a portfolio approach: low-cost proof-of-concept investments in near-term optimization use cases now, combined with a talent-building program and vendor relationship development that positions the firm to move quickly when fault-tolerant hardware crosses the threshold for each firm’s priority use cases.